German group Bayer, which operates in the pharmaceutical,
agricultural sector and in the auto industry, expects a similar
turnover this year on the Romanian market to the 2008 figure, while
growth could be achieved in 2010. The group posted 91 million euros
in turnover on the Romanian market last year. “We did not start in
an easy time. Many changes have occurred in the drug industry. One
of them is the clawback system (a sales tax i.e.), while another is
the extension of deadlines,” says Andreas Damaske, general manager
of Bayer SRL, in an interview given to ZF. Damaske took over at the
helm of the company in July this year, replacing Laurent Perrier.
Bayer’s international business consists of several divisions
operating in different sectors: HealthCare (drugs), CropScience
(agriculture) and MaterialScience (auto industry and construction
materials industry), and Bayer Agency Business. In Romania, the
group has these divisions grouped together under the Bayer SRL
umbrella. Apart from being general manager of Bayer SRL, Damaske is
also head of the HealthCare division. The Romanian healthcare
division consists of Bayer Schering Pharma and Bayer Consumer Care.
“I have three jobs in fact. I am general manager of Bayer SRL, a
position we call Senior Bayer Representative. I am also Bayer
Healthcare Representative and country division head of Bayer
Schering Pharma,” Damaske explains.

Subiecte #Andreas Damaske#Bayer